Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carbon Isotopes | 6 | 2019 | 54 | 1.610 |
Why?
|
| Cerclage, Cervical | 4 | 2013 | 11 | 1.380 |
Why?
|
| Laparoscopy | 6 | 2013 | 237 | 1.260 |
Why?
|
| Oxygen Isotopes | 5 | 2020 | 7 | 0.970 |
Why?
|
| Nitrogen Isotopes | 5 | 2020 | 13 | 0.930 |
Why?
|
| Amino Acids | 2 | 2019 | 131 | 0.850 |
Why?
|
| Forensic Sciences | 6 | 2009 | 9 | 0.780 |
Why?
|
| Mass Spectrometry | 6 | 2019 | 284 | 0.780 |
Why?
|
| Metabolomics | 1 | 2019 | 28 | 0.710 |
Why?
|
| Device Removal | 2 | 2013 | 100 | 0.700 |
Why?
|
| Isotopes | 5 | 2009 | 15 | 0.570 |
Why?
|
| Coffea | 1 | 2015 | 1 | 0.540 |
Why?
|
| Seeds | 1 | 2015 | 23 | 0.530 |
Why?
|
| Alcoholic Beverages | 1 | 2015 | 18 | 0.520 |
Why?
|
| Food Contamination | 1 | 2015 | 56 | 0.510 |
Why?
|
| Pregnancy Outcome | 3 | 2009 | 157 | 0.450 |
Why?
|
| N-Methyl-3,4-methylenedioxyamphetamine | 4 | 2010 | 19 | 0.440 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2013 | 45 | 0.440 |
Why?
|
| Sutures | 2 | 2013 | 32 | 0.420 |
Why?
|
| Honey | 2 | 2021 | 5 | 0.400 |
Why?
|
| Laparotomy | 3 | 2009 | 65 | 0.390 |
Why?
|
| Paper | 3 | 2005 | 23 | 0.360 |
Why?
|
| Laboratories | 1 | 2009 | 44 | 0.340 |
Why?
|
| Deuterium | 2 | 2020 | 10 | 0.330 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2019 | 381 | 0.320 |
Why?
|
| Product Packaging | 2 | 2005 | 17 | 0.320 |
Why?
|
| Spectrum Analysis | 2 | 2005 | 81 | 0.320 |
Why?
|
| 3,4-Methylenedioxyamphetamine | 2 | 2007 | 2 | 0.300 |
Why?
|
| Obstetrics | 1 | 2006 | 44 | 0.280 |
Why?
|
| Gynecology | 1 | 2006 | 46 | 0.280 |
Why?
|
| Abdomen | 3 | 2013 | 80 | 0.270 |
Why?
|
| Faculty, Medical | 1 | 2006 | 110 | 0.270 |
Why?
|
| Pregnancy | 5 | 2013 | 2331 | 0.260 |
Why?
|
| Adnexal Diseases | 1 | 2004 | 2 | 0.240 |
Why?
|
| Pelvic Pain | 1 | 2004 | 11 | 0.240 |
Why?
|
| Cocaine | 2 | 2005 | 555 | 0.200 |
Why?
|
| Clinical Competence | 1 | 2006 | 657 | 0.200 |
Why?
|
| Hydrogen | 3 | 2010 | 35 | 0.200 |
Why?
|
| Sulfur Isotopes | 1 | 2020 | 2 | 0.190 |
Why?
|
| Flour | 1 | 2020 | 3 | 0.190 |
Why?
|
| Pregnancy Complications | 1 | 2004 | 286 | 0.190 |
Why?
|
| Plant Oils | 1 | 2020 | 31 | 0.190 |
Why?
|
| Pregnancy Trimester, Second | 2 | 2013 | 58 | 0.190 |
Why?
|
| Internship and Residency | 1 | 2006 | 596 | 0.190 |
Why?
|
| Hydrolysis | 1 | 2019 | 144 | 0.180 |
Why?
|
| Australia | 2 | 2021 | 235 | 0.170 |
Why?
|
| Ninhydrin | 1 | 2018 | 1 | 0.170 |
Why?
|
| Flow Injection Analysis | 1 | 2018 | 1 | 0.170 |
Why?
|
| Ambulatory Surgical Procedures | 2 | 2009 | 33 | 0.160 |
Why?
|
| Collagen | 1 | 2020 | 636 | 0.150 |
Why?
|
| Crustacea | 1 | 2016 | 7 | 0.140 |
Why?
|
| Trace Elements | 1 | 2016 | 23 | 0.140 |
Why?
|
| Africa | 1 | 2015 | 41 | 0.130 |
Why?
|
| Discriminant Analysis | 1 | 2015 | 36 | 0.130 |
Why?
|
| India | 1 | 2015 | 41 | 0.130 |
Why?
|
| Pyrus | 1 | 2015 | 2 | 0.130 |
Why?
|
| Australasia | 1 | 2015 | 2 | 0.130 |
Why?
|
| Malus | 1 | 2015 | 4 | 0.130 |
Why?
|
| New Zealand | 1 | 2015 | 28 | 0.130 |
Why?
|
| Carbohydrates | 1 | 2015 | 57 | 0.130 |
Why?
|
| Environmental Monitoring | 1 | 2016 | 180 | 0.130 |
Why?
|
| Europe | 1 | 2015 | 195 | 0.130 |
Why?
|
| Fruit | 1 | 2015 | 86 | 0.120 |
Why?
|
| Heroin | 2 | 2005 | 49 | 0.120 |
Why?
|
| Adult | 6 | 2013 | 21375 | 0.120 |
Why?
|
| Water | 1 | 2015 | 228 | 0.120 |
Why?
|
| Laminaria | 1 | 2013 | 3 | 0.110 |
Why?
|
| Dilatation and Curettage | 1 | 2013 | 5 | 0.110 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 4 | 2007 | 59 | 0.100 |
Why?
|
| Water Pollutants, Chemical | 1 | 2016 | 328 | 0.100 |
Why?
|
| Adrenergic Uptake Inhibitors | 1 | 2010 | 20 | 0.090 |
Why?
|
| Humans | 9 | 2013 | 68525 | 0.090 |
Why?
|
| Prospective Studies | 2 | 2009 | 3702 | 0.090 |
Why?
|
| Animals | 4 | 2021 | 20877 | 0.090 |
Why?
|
| Uterine Cervical Incompetence | 1 | 2009 | 4 | 0.090 |
Why?
|
| Abortion, Habitual | 1 | 2009 | 13 | 0.090 |
Why?
|
| Explosions | 1 | 2009 | 4 | 0.090 |
Why?
|
| Female | 6 | 2013 | 38015 | 0.090 |
Why?
|
| Explosive Agents | 1 | 2009 | 3 | 0.090 |
Why?
|
| Reference Standards | 1 | 2009 | 115 | 0.090 |
Why?
|
| Hallucinogens | 1 | 2007 | 14 | 0.080 |
Why?
|
| Polyethylene Terephthalates | 1 | 2007 | 29 | 0.080 |
Why?
|
| Fetal Death | 1 | 2007 | 49 | 0.080 |
Why?
|
| Hysteroscopy | 1 | 2006 | 3 | 0.070 |
Why?
|
| Sterilization, Tubal | 1 | 2006 | 5 | 0.070 |
Why?
|
| Physicians' Offices | 1 | 2006 | 8 | 0.070 |
Why?
|
| Recurrence | 1 | 2009 | 948 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2009 | 2077 | 0.070 |
Why?
|
| Prostheses and Implants | 1 | 2007 | 159 | 0.070 |
Why?
|
| Drug Packaging | 1 | 2005 | 4 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2006 | 306 | 0.070 |
Why?
|
| Operating Rooms | 1 | 2006 | 108 | 0.070 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2005 | 67 | 0.060 |
Why?
|
| Narcotics | 1 | 2005 | 65 | 0.060 |
Why?
|
| Retrospective Studies | 2 | 2009 | 7264 | 0.060 |
Why?
|
| Technology, Pharmaceutical | 1 | 2003 | 8 | 0.060 |
Why?
|
| Tablets | 1 | 2003 | 19 | 0.060 |
Why?
|
| Forensic Medicine | 1 | 2003 | 26 | 0.060 |
Why?
|
| England | 1 | 2003 | 64 | 0.060 |
Why?
|
| Automation | 1 | 2003 | 45 | 0.060 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2003 | 236 | 0.060 |
Why?
|
| Drug and Narcotic Control | 1 | 2002 | 15 | 0.050 |
Why?
|
| Dronabinol | 1 | 2003 | 84 | 0.050 |
Why?
|
| Disaccharides | 1 | 2021 | 9 | 0.050 |
Why?
|
| Sugars | 1 | 2021 | 7 | 0.050 |
Why?
|
| Bees | 1 | 2021 | 8 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2002 | 346 | 0.050 |
Why?
|
| Fish Proteins | 1 | 2020 | 20 | 0.050 |
Why?
|
| Fishes | 1 | 2020 | 77 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 1753 | 0.040 |
Why?
|
| Young Adult | 1 | 2009 | 5708 | 0.040 |
Why?
|
| Equipment Design | 1 | 2018 | 500 | 0.040 |
Why?
|
| Pacific Ocean | 1 | 2016 | 10 | 0.040 |
Why?
|
| Asia | 1 | 2016 | 59 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2004 | 7028 | 0.030 |
Why?
|
| Adolescent | 1 | 2004 | 8903 | 0.020 |
Why?
|
| Platinum | 1 | 2010 | 17 | 0.020 |
Why?
|
| Pentaerythritol Tetranitrate | 1 | 2009 | 1 | 0.020 |
Why?
|
| Heterocyclic Compounds, 1-Ring | 1 | 2009 | 4 | 0.020 |
Why?
|
| Peroxides | 1 | 2009 | 23 | 0.020 |
Why?
|
| Plastics | 1 | 2009 | 25 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2006 | 652 | 0.020 |
Why?
|
| Solvents | 1 | 2005 | 108 | 0.020 |
Why?
|
| Pattern Recognition, Automated | 1 | 2003 | 70 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2006 | 3256 | 0.010 |
Why?
|
| Time Factors | 1 | 2006 | 4655 | 0.010 |
Why?
|